GlaxoSmithKline Pharmaceuticals Limited (GLAXO)-Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Limited (GLAXO)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH113643FSA
  • |
  • Pages: 47
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

GlaxoSmithKline Pharmaceuticals Limited (GLAXO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlaxoSmithKline Pharmaceuticals Limited (GSK India) is a pharmaceutical company that manufactures and markets prescription medicines and vaccines. The prescription medicines range across therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, central nervous system (CNS) and oncology. The company offers a range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus, tetanus toxoid, reduced diphtheria toxoid, human papillomavirus vaccine and others. The company is a subsidiary of GlaxoSmithKline Plc, which has operations across pharmaceuticals, vaccines and consumer health domains. GSK India is headquartered in Mumbai, Maharashtra, India.

GlaxoSmithKline Pharmaceuticals Limited Key Recent Developments

Jul 28, 2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth

Mar 04, 2016: WNS Extends Contract with GSK to Provide High-end Analytical Services

Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration

Jan 12, 2016: Kuehne + Nagel and GlaxoSmithKline sign long term global logistics partnership contract

Sep 08, 2015: GSK Initiates Work On Pharmaceutical Facility In Karnataka, India

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

GlaxoSmithKline Pharmaceuticals Limited-Key Facts 6

GlaxoSmithKline Pharmaceuticals Limited-Key Employees 7

GlaxoSmithKline Pharmaceuticals Limited-Key Employee Biographies 8

GlaxoSmithKline Pharmaceuticals Limited-Major Products and Services 9

GlaxoSmithKline Pharmaceuticals Limited-History 14

GlaxoSmithKline Pharmaceuticals Limited-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Joint Venture 17

Section 2-Company Analysis 18

GlaxoSmithKline Pharmaceuticals Limited-Business Description 18

GlaxoSmithKline Pharmaceuticals Limited-Corporate Strategy 19

GlaxoSmithKline Pharmaceuticals Limited-SWOT Analysis 20

SWOT Analysis-Overview 20

GlaxoSmithKline Pharmaceuticals Limited-Strengths 20

Strength-Parent Synergy 20

Strength-Focused Research Activities 20

Strength-Strong Market Position 20

GlaxoSmithKline Pharmaceuticals Limited-Weaknesses 21

Weakness-Anti-Competitive Practices 21

Weakness-Declined Sales 21

GlaxoSmithKline Pharmaceuticals Limited-Opportunities 22

Opportunity-Strategic Initiatives 22

Opportunity-Changing Demographics 22

Opportunity-Facility Expansions 22

GlaxoSmithKline Pharmaceuticals Limited-Threats 23

Threat-Government Regulations 23

Threat-Uncertain R&D Outcomes 23

Threat-Competitive Landscape 23

GlaxoSmithKline Pharmaceuticals Limited-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

GlaxoSmithKline Pharmaceuticals Limited, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Jul 28, 2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth 33

Mar 04, 2016: WNS Extends Contract with GSK to Provide High-end Analytical Services 34

Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration 35

Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration 36

Jan 12, 2016: Kuehne + Nagel and GlaxoSmithKline sign long term global logistics partnership contract 37

Sep 08, 2015: GSK Initiates Work On Pharmaceutical Facility In Karnataka, India 38

Aug 02, 2015: GSK India's Greenfield Manufacturing Facility At Bengaluru To Begin Operations In 2017 39

Jun 22, 2015: GlaxoSmithKline Pharmaceuticals appoints Annaswamy Vaidheesh as MD 40

Jun 08, 2015: GSK Considering All Options Against CCI Order 41

Feb 12, 2015: GlaxoSmithKline Pharmaceuticals announces Q4 Results 42

Section 6-Appendix 43

Methodology 43

Ratio Definitions 43

About GlobalData 47

Contact Us 47

Disclaimer 47

List of Figures

GlaxoSmithKline Pharmaceuticals Limited, Performance Chart (2012-2016) 28

GlaxoSmithKline Pharmaceuticals Limited, Ratio Charts 29

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 31

List of Tables

GlaxoSmithKline Pharmaceuticals Limited, Key Facts 6

GlaxoSmithKline Pharmaceuticals Limited, Key Employees 7

GlaxoSmithKline Pharmaceuticals Limited, Key Employee Biographies 8

GlaxoSmithKline Pharmaceuticals Limited, Major Products and Services 9

GlaxoSmithKline Pharmaceuticals Limited, History 14

GlaxoSmithKline Pharmaceuticals Limited, Joint Venture 17

GlaxoSmithKline Pharmaceuticals Limited, Key Competitors 24

GlaxoSmithKline Pharmaceuticals Limited, Ratios based on current share price 25

GlaxoSmithKline Pharmaceuticals Limited, Annual Ratios 26

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 30

GlaxoSmithKline Pharmaceuticals Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 31

GlaxoSmithKline Pharmaceuticals Limited, Recent Deals Summary 32

Currency Codes 43

Capital Market Ratios 43

Equity Ratios 44

Profitability Ratios 44

Cost Ratios 45

Liquidity Ratios 45

Leverage Ratios 46

Efficiency Ratios 46

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

GlaxoSmithKline Pharmaceuticals Limited, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 300 INR 19515
Site License
USD 600 INR 39030
Corporate User License
USD 900 INR 58545

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com